Inogen | 当期純利益





当期純利益 変化する 日付
Abbott USD 1.78B 132M 2025-12
AngioDynamics USD -4.41M 6.33M 2025-02
AtriCure USD -267K 5.92M 2025-09
Baxter International USD -46M 137M 2025-09
Becton, Dickinson and Co. USD 382M 111M 2025-12
Boston Scientific USD 672M 83M 2025-12
Chart Industries USD -145.3M 214.6M 2025-09
Cooper Companies USD 84.6M 13.7M 2025-09
Dexcom USD 179.8M 74.4M 2025-06
Edwards Lifesciences USD 291.1M 42.1M 2025-09
Globus Medical USD 118.97M 83.88M 2025-09
Inogen USD -5.96M 373K 2024-09
Insulet USD 87.6M 65.1M 2025-09
Masimo USD -100.4M 151.7M 2025-09
Medtronic USD 1.37B 334M 2025-09
Orthofix International USD -126M 98.61M 2024-12
Philips EUR 395M 211M 2025-12
ResMed USD 392.59M 44.06M 2025-12
Steris USD 192.9M 1000K 2025-12
Stryker USD 849M 10M 2025-12
Tandem Diabetes Care USD -21.16M 31.24M 2025-09
Teleflex USD -408.89M 531.47M 2025-09
X T L Biopharmaceuticals USD -255K 298K 2024-12
Zimmer Biomet Holdings USD 139.3M 91.6M 2025-12


Inogen 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.